Managing the adverse events of intravesical bacillus Calmette–Guérin therapy

This paper provides recommendations on the management of complications arising from intravesical treatment with bacillus Calmette–Guérin (BCG) for nonmuscle-invasive bladder tumors. There is minimal recommendations currently available as randomized trials on the side effects of intravesical BCG are...

Descripción completa

Detalles Bibliográficos
Autores principales: Decaestecker, Karel, Oosterlinck, Willem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630183/
https://www.ncbi.nlm.nih.gov/pubmed/26605208
http://dx.doi.org/10.2147/RRU.S63448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630183/
https://www.ncbi.nlm.nih.gov/pubmed/26605208
http://dx.doi.org/10.2147/RRU.S63448

Ejemplares similares